Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab. 2008  ;93(9):3357-64.

Kizer JR, Arnold AM, Strotmeyer ES, Ives DG, Cushman M, Ding J, Kritchevsky SB, Chaves PHM, Hirsch CH, Newman AB. Change in circulating adiponectin in advanced old age: determinants and impact on physical function and mortality. The Cardiovascular Health Study All Stars Study. J Gerontol A Biol Sci Med Sci. 2010  ;65(11):1208-14.

Kilpeläinen TO, Zillikens CM, Stan?áková A, Finucane FM, Ried JS, Langenberg C, Zhang W, Beckmann JS, Luan J'an, Vandenput L, et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet. 2011  ;43(8):753-60.

Kizer JR, Arnold AM, Jenny NS, Cushman M, Strotmeyer ES, Ives DG, Ding J, Kritchevsky SB, Chaves PHM, Hirsch CH, et al. Longitudinal changes in adiponectin and inflammatory markers and relation to survival in the oldest old: the Cardiovascular Health Study All Stars study. J Gerontol A Biol Sci Med Sci. 2011  ;66(10):1100-7.

Kizer JR, Benkeser D, Arnold AM, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, Mantzoros CS, deFilippi CR, et al. Associations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study. Circulation. 2012  ;126(25):2951-61.

Dastani Z, Hivert M-F, Timpson N, Perry JRB, Yuan X, Scott RA, Henneman P, Heid IM, Kizer JR, Lyytikäinen L-P, et al. Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012  ;8(3):e1002607.

Kizer JR, Arnold AM, Benkeser D, Ix JH, Djoussé L, Zieman SJ, Barzilay JI, Tracy RP, Mantzoros CS, Siscovick DS, et al. Total and high-molecular-weight adiponectin and risk of incident diabetes in older people. Diabetes Care. 2012  ;35(2):415-23.

Kizer JR, Benkeser D, Arnold AM, Djoussé L, Zieman SJ, Mukamal KJ, Tracy RP, Mantzoros CS, Siscovick DS, Gottdiener JS, et al. Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adults. J Clin Endocrinol Metab. 2013  ;98(1):255-63.

Sanders JL, Ding V, Arnold AM, Kaplan RC, Cappola AR, Kizer JR, Boudreau RM, Cushman M, Newman AB. Do changes in circulating biomarkers track with each other and with functional changes in older adults?. J Gerontol A Biol Sci Med Sci. 2014  ;69(2):174-81.

Karas MG, Benkeser D, Arnold AM, Bartz TM, Djoussé L, Mukamal KJ, Ix JH, Zieman SJ, Siscovick DS, Tracy RP, et al. Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ?65 years of age (from the Cardiovascular Health study). Am J Cardiol. 2014  ;113(2):328-34.

Macheret F, Bartz TM, Djoussé L, Ix JH, Mukamal KJ, Zieman SJ, Siscovick DS, Tracy RP, Heckbert SR, Psaty BM, et al. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. Heart. 2015  ;101(17):1368-74.